Abbvie Inc (NYSE:ABBV)
| 118.53 Delayed Data As of Jul 28 |  +0.57 / +0.48%Today’s Change | 79.11 Today|||52-Week Range 118.93 | +10.62% Year-to-Date |
Latest ABBV News | Press Releases
Today’s Trading
| Previous close | 117.96 |
| Today’s open | 117.83 |
| Day’s range | 117.31 - 118.93 |
| Volume | 5,650,734 |
| Average volume (3 months) | 6,425,703 |
| Market cap | $208.7B |
Data as of 4:00pm ET, 07/28/2021
Growth & Valuation
| Earnings growth (last year) | -48.39% |
| Earnings growth (this year) | +19.32% |
| Earnings growth (next 5 years) | +3.30% |
| Revenue growth (last year) | +37.69% |
| P/E ratio | 44.1 |
| Price/Sales | 3.91 |
| Price/Book | 15.95 |
Competitors
| Today’s change | Today’s % change | |
|---|---|---|
| NVSNovartis | +0.58 | +0.63% |
| MRKMerck | +0.28 | +0.36% |
| LLYEli Lilly and Co | +2.91 | +1.19% |
| PFEPfizer | +0.97 | +2.30% |
Data as of 5:39pm ET, 07/28/2021
Financials
| Next reporting date | July 30, 2021 |
| EPS forecast (this quarter) | $3.08 |
| Annual revenue (last year) | $45.8B |
| Annual profit (last year) | $4.6B |
| Net profit margin | 9.95% |
Profile
Sector Health Technology |
Industry Pharmaceuticals: Major |
No executives to display |
Corporate headquarters North Chicago, Illinois |
Forecasts
